TO THE EDffOR We read with interest the article of Rieker et al.(1) concerning the use of
radioimmune bone marrow scintig raphy in patients with disseminated bone marrow …

Bone marrow scintigraphy using" To-labeled monoclonal an tibodies (BW 250/183)
demonstrated diffuse destruction of bone marrow due to metastatic disease and consecutive …

(11). Plasma free activity at 10 mm and 1 hr postinjection is 85% and 20%, respectively (11).
At 5 hr postinjection 18% — 21% of whole-body radioactivity is localized in the liver, and …

This editorial commentary refers to the article http://dx. doi. org/10.1007/s00259-005-1842-8
Positron emission tomography (PET) is changing the practice of oncology and in addition …

Attempts were made to assess the value of various methods of demonstration of bone
metastases in patients with recurrence of cancer of the breast. A material of 123 patients with …

TO THE EDITOR:''Where have all the flowers gone, long time passing?''Pete Seeger's
antiwar song became famous when Marlene Dietrich interpreted the German version ''Sag …

This prospective study evaluates bone marrow scintigraphy (BMS) in detecting bone
metastases from primary breast cancer when performed in complement to conventional …

[en] Radioimmunoimaging of bone marrow was performed for non-invasive detection of
skeletal involvement in 15 patients with carcinoma of the breast and 17 patients with …

Radioimmunoimaging of bone marrow was performed for non-invasive detection of skeletal
involvement in 15 patients with carcinoma of the breast and 17 patients with malignant …

Metastatic bone disease was evaluated in 380 consecutive patients at the time of first
metastasis of breast cancer. Studies included radiographic examination, radionuclide …